Health X Platform sets date for FY26 results
The company has issued a routine board meeting notice to approve its audited results for the quarter and year ended March 31, 2026.
— 4 earlier stories on Health X Platform Ltd. →What's new
- Health X Platform board to meet to approve audited annual and Q4 financials.
- Trading window closed as a standard compliance measure for the reporting period.
- No financial guidance or material surprises in this procedural filing.
Why this matters
This is a routine calendar event. Investors looking for signals in this filing will not find them.
What we're watching
- The eventual release of audited FY26 results.
- Any variance from previously communicated earnings guidance.
The full read
Health X Platform has issued a standard board meeting intimation to approve its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. This disclosure is a routine procedural requirement under SEBI regulations. The company also confirmed the closure of its trading window, which is a standard compliance measure ahead of earnings releases. The filing contains no new financial data, guidance, or operational updates. It is a scheduled event that carries no surprise for the market. Investors should treat this as a standard corporate calendar item.
Health X Platform Ltd.
Latest quarter · Mar 2026
Leverage & growth
Story so far
All notes on HEALTHX →- 22 May 2026 · 5:59 PM IST Health X Platform sets date for FY26 results
- 23d ago Health X transcript confirms FY30 revenue target of ₹6,000 cr
- 30d ago Health X targets ₹6,000 cr FY30 revenue, Q1 hits ₹400 cr
- 32d ago Health X splits its tiny finance arm, absorbs core healthcare unit into parent
- 37d ago Health X promoter sheds 0.79% stake for ₹7.5 cr